These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38146526)

  • 21. Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
    Dick AD; Tundia N; Sorg R; Zhao C; Chao J; Joshi A; Skup M
    Ophthalmology; 2016 Mar; 123(3):655-62. PubMed ID: 26712559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study.
    Paredes MI; Lunn SM; Famulare M; Frisbie LA; Painter I; Burstein R; Roychoudhury P; Xie H; Mohamed Bakhash SA; Perez R; Lukes M; Ellis S; Sathees S; Mathias PC; Greninger A; Starita LM; Frazar CD; Ryke E; Zhong W; Gamboa L; Threlkeld M; Lee J; McDermot E; Truong M; Nickerson DA; Bates DL; Hartman ME; Haugen E; Nguyen TN; Richards JD; Rodriguez JL; Stamatoyannopoulos JA; Thorland E; Melly G; Dykema PE; MacKellar DC; Gray HK; Singh A; Peterson JM; Russell D; Torres LM; Lindquist S; Bedford T; Allen KJ; Oltean HN
    Clin Infect Dis; 2022 Aug; 75(1):e536-e544. PubMed ID: 35412591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications.
    Khan N; Mahmud N
    Gastroenterology; 2021 Sep; 161(3):827-836. PubMed ID: 34048782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World Incidence of Incident Noninfectious Uveitis in Patients Treated With BRAF Inhibitors: A Nationwide Clinical Cohort Study.
    Jung H; Kim S; Lee CS; Byeon SH; Kim SS; Lee SW; Kim YJ
    Am J Ophthalmol; 2024 Jul; 267():142-152. PubMed ID: 38977151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
    Marchetti M; Salmanton-García J; El-Ashwah S; Verga L; Itri F; Ráčil Z; Dávila-Valls J; Martín-Pérez S; Van Doesum J; Passamonti F; Abu-Zeinah G; Farina F; López-García A; Dragonetti G; Cattaneo C; Gomes Da Silva M; Bilgin YM; Žák P; Petzer V; Glenthøj A; Espigado I; Buquicchio C; Bonuomo V; Prezioso L; Meers S; Duarte R; Bergantim R; Jaksic O; Čolović N; Blennow O; Cernan M; Schönlein M; Samarkos M; Mitra ME; Magliano G; Maertens J; Ledoux MP; Jiménez M; Demirkan F; Collins GP; Cabirta A; Gräfe SK; Nordlander A; Wolf D; Arellano E; Cordoba R; Hanakova M; Zambrotta GPM; Nunes Rodrigues R; Limberti G; Marchesi F; Cornely OA; Pagano L
    Ther Adv Hematol; 2023; 14():20406207231154706. PubMed ID: 36923264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
    Hanberg JS; Fu X; Wang X; Patel NJ; Kawano Y; Schiff A; Kowalski EN; Cook CE; Vanni KMM; Guzzo K; Qian G; Bade KJ; Saavedra A; Venkat R; Srivatsan S; Zhang Y; Sparks JA; Wallace ZS
    Lancet Rheumatol; 2024 Jan; 6(1):e21-e30. PubMed ID: 38258675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States.
    Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR
    Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.
    Agrawal R; Gunasekeran DV; Grant R; Agarwal A; Kon OM; Nguyen QD; Pavesio C; Gupta V;
    JAMA Ophthalmol; 2017 Dec; 135(12):1318-1327. PubMed ID: 29075752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
    Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
    Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials.
    Suhler EB; Thorne JE; Mittal M; Betts KA; Tari S; Camez A; Bao Y; Joshi A
    Ophthalmology; 2017 Dec; 124(12):1799-1807. PubMed ID: 28689898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
    Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of COVID-19 Among Unvaccinated and Vaccinated Patients With Rheumatoid Arthritis: A General Population Study.
    Li H; Wallace ZS; Sparks JA; Lu N; Wei J; Xie D; Wang Y; Zeng C; Lei G; Zhang Y
    Arthritis Care Res (Hoboken); 2023 May; 75(5):956-966. PubMed ID: 36161711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients.
    Maalouf G; Andrillon A; Leclercq M; Sève P; Bielefeld P; Gueudry J; Sené T; Titah C; Moulinet T; Rouvière B; Sène D; Desbois AC; Domont F; Touhami S; Thibault T; Chamieh CE; Cacoub P; Kodjikian L; Biard L; Bodaghi B; Saadoun D
    Am J Ophthalmol; 2022 Jun; 238():173-180. PubMed ID: 35172172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.
    Smith JB; Gonzales EG; Li BH; Langer-Gould A
    JAMA Netw Open; 2022 Dec; 5(12):e2248664. PubMed ID: 36576740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY).
    Agarwal AK; Sudharshan S; Mahendradas P; Babu K; Shenoy P; Dogra M; Bansal R; Agarwal M; Biswas J; Balamurugan S; Agrawal R; Gupta V
    Br J Ophthalmol; 2022 Jan; 106(1):97-101. PubMed ID: 33011688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of COVID-19 Infection With Incident Diabetes.
    Naveed Z; Velásquez García HA; Wong S; Wilton J; McKee G; Mahmood B; Binka M; Rasali D; Janjua NZ
    JAMA Netw Open; 2023 Apr; 6(4):e238866. PubMed ID: 37071420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
    PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India.
    Biswas J; Tyagi M; Agarwal M;
    Ophthalmol Sci; 2024; 4(1):100403. PubMed ID: 38027419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.